Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent and Shimadzu to Exchange Chromatography Instrument Drivers

Published: Wednesday, May 29, 2013
Last Updated: Wednesday, May 29, 2013
Bookmark and Share
The standardization will reduce costs, enhance interoperability and broaden customer choice.

Agilent Technologies Inc. and Shimadzu Corp. announce that they will exchange RapidControl.NET (RC.Net) instrument drivers. Shimadzu’s adoption and support of Agilent’s RC.Net driver standard strengthens RC.Net as an emerging open industry standard for instrument control across multiple data systems.

Through this exchange, Shimadzu LabSolutions and Agilent OpenLAB Chromatography Data Systems will control both manufacturers’ instruments, providing customers more freedom of choice in instrumentation for their laboratories, regardless of which CDS they use. In addition, customers can preserve their investment in workflow definition and supporting operating procedures.

“At Agilent, we are fully committed to bringing instrument control solutions for the most popular chromatography instruments into OpenLAB CDS,” said Bruce von Herrmann, general manager of Agilent Software and Informatics. “Our agreement with Shimadzu represents the continued cooperation of both companies. OpenLAB CDS customers will now be able to utilize the features and functions of their Shimadzu instrumentation on our newest CDS product.”

“At Shimadzu, we are dedicated to providing flexible instrumentation and software solutions for our customers,” said Masami Tomita, Shimadzu general manager of LC Business Unit, Life Science Business Department. “We are pleased to announce that Shimadzu instruments are now able to be controlled by Agilent OpenLAB CDS. Our collaboration will provide a more integrated solution for customers who require a single CDS product to provide seamless multi-vendor control of all instruments in their laboratory. This will allow any CDS which supports RC.Net to control our instruments. Shimadzu’s adoption and implementation of the RC.Net standard will also enable Agilent instruments to be controlled by Shimadzu LabSolutions CDS.”

The new Shimadzu RC.Net drivers will initially support Shimadzu’s Nexera and Prominence HPLC lines. These drivers will be made available on Agilent’s OpenLAB CDS later this month. Shimadzu’s LabSolutions CDS will gain the Agilent HPLC RC.Net drivers, supporting Agilent’s 1100, 1200, 1260 and 1290 series instruments. This integration is expected to occur in August.

For GCs, the new Shimadzu RC.Net drivers will initially support Shimadzu’s GC-2010/Plus and GC-2014 product lines in exchange for Agilent’s GC RC.Net drivers supporting Agilent 6890, 7820 and 7890 series instruments. The expected timing for completing this development is late 2013. 

For more information about Shimadzu’s LabSolutions chromatography systems, visit www.shimadzu.com/an/data-net

For more information about Agilent OpenLAB CDS, visit www.chem.agilent.com/en-US/Products-Services/Software-Informatics


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Technologies to Build New Facility in Colorado
Agilent buys 20 acres in Weld County to increase pharmaceutical manufacturing capacity.
Wednesday, August 10, 2016
Dako Announces CE Mark for Companion Diagnostic
Dako has announced the CE Mark certification for use of PD-L1, a companion diagnostic to Merck's anti-PD-1 immunotherapy Keytruda.
Thursday, August 04, 2016
Agilent to Acquire iLab Solutions
Companies have announced they have signed a definitive agreement under which Agilent will acquire substantially all of the assets of iLab, the market leader in cloud-based solutions for core laboratory management.
Wednesday, June 29, 2016
Agilent, Eurofins Genomics Collaborate
Agilent plans to offer custom components and an assembled plasmid service for Agilent’s SureVector next-generation cloning kits through a collaboration with Eurofins.
Monday, March 14, 2016
Best Practices for Breast Cancer Diagnosis
Agilent has published “Breast Cancer Diagnosis: Past, Present and Future,” a white paper on the use of immunohistochemistry in diagnosing and treating breast cancer.
Monday, March 14, 2016
Agilent Invests $80M in Lasergen
Company has announced that it has invested $80 million in Lasergen, with innovative next-generation sequencing technology for clinical applications.
Friday, March 11, 2016
Agilent Technologies Announces Early Access to Custom guideRNA for Functional Genomics
Company has announced a program that gives biologists conducting functional genomics research early access to a potential new resource.
Saturday, February 13, 2016
Agilent Technologies and 10x Genomics Announce Collaboration
Company has announced collaboration to develop a premium exome that provides a streamlined workflow for 10x Genomics'Chromium platform.
Friday, February 12, 2016
Agilent Wins Award for Innovation in LC
Dual-needle technology enhances speed, flexibility.
Thursday, January 28, 2016
Agilent Extends Agreement with PerkinElmer on Bioanalyzer Chips
PerkinElmer supplies chips for Agilent's popular 2100 Bioanalyzer system.
Thursday, January 21, 2016
Agilent Signs Agreement with Thermo Fisher Scientific
Agreement to exchange instrument controls to improve the productivity and user experience.
Thursday, November 12, 2015
Agilent Completes Acquisition of Seahorse Bioscience
Agilent has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics.
Tuesday, November 03, 2015
Agilent Recognizes Australian Genome Research Facility as Certified Service Provider
Nonprofit organization offers scientists access to leading-edge technologies.
Saturday, October 31, 2015
Agilent Announces Opening of Life Science Research Center
Facility designed to advance multi-omics research.
Thursday, September 24, 2015
Agilent to Acquire Seahorse Bioscience
Acquisition complements Agilent’s market-leading separations and mass spectrometry solutions, expands pharma offerings.
Thursday, September 10, 2015
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!